ST. LUKES HOSPITAL OF DULUTH
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.1M
- Transactions
- 559
- Companies
- 28
- Average per transaction
- $3,736
Who reported the payments
| AstraZeneca | $1,160,592 |
| Cardiofocus, Inc. | $309,850 |
| AbbVie | $141,286 |
| Janssen Research & Development, LLC | $104,460 |
| CSL Behring | $90,941 |
| Smith+Nephew | $73,569 |
| Boston Scientific | $58,091 |
| Astrazeneca UK Limited | $33,946 |
| Sanofi Pasteur Inc. | $15,760 |
| Abbott | $13,002 |
| Pfizer | $11,350 |
| Merck | $10,776 |
| Johnson & Johnson | $9,901 |
| Stryker | $9,334 |
| Bard Peripheral Vascular, Inc. | $9,209 |
| Medline Industries LP | $7,314 |
| Eli Lilly | $6,515 |
| Olympus America Inc. | $5,769 |
| Baxter Healthcare | $4,564 |
| Philips North America LLC | $3,800 |
| Merge Healthcare Incorporated | $2,078 |
| Linvatec Corporation | $1,917 |
| F. Hoffmann-la Roche AG | $1,371 |
| Aesculap, Inc. | $1,144 |
| Novartis | $600 |
| Amgen | $600 |
| Leica Microsystems Inc. | $407 |
| Cochlear Americas | $229 |